SEC 13F Intelligence

Two Sigma Advisers, LP / ABBV

Two Sigma Advisers, LP’s Abbvie Inc Position

Does Two Sigma Advisers, LP own Abbvie Inc (ABBV)? Not currently — the last reported position was 165.4K shares worth $38M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$38M
Q4 2025
Shares
165.4K
% of Portfolio
+0.07%
Quarters Held
27
position exited

Position History ABBV

Reported value by quarter
Q4 ’18: $119MQ4 ’18Q1 ’19: $408MQ2 ’19: $431MQ3 ’19: $476MQ4 ’19: $506MQ4 ’19Q1 ’20: $198MQ2 ’20: $410MQ3 ’20: $381MQ4 ’20: $392MQ4 ’20Q1 ’21: $380MQ2 ’21: $276MQ3 ’21: $43MQ4 ’21: $285MQ4 ’21Q1 ’22: $356MQ2 ’22: $53MQ3 ’22: $26MQ4 ’22: $5MQ4 ’22Q1 ’23: $111MQ2 ’23: $165MQ3 ’23: $220MQ4 ’23: $162MQ4 ’23Q1 ’24: $85MQ2 ’24: $43MQ1 ’25: $910,155Q2 ’25: $3MQ2 ’25Q3 ’25: $14MQ4 ’25: $38Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 2025165.4K$38M+0.07%
Q3 202559.3K$14M+0.03%
Q2 202513.6K$3M+0.01%
Q1 20254.3K$910,1550.00%
Q2 2024250.2K$43M+0.10%
Q1 2024466.7K$85M+0.20%
Q4 20231.04M$162M+0.38%
Q3 20231.48M$220M+0.56%
Q2 20231.23M$165M+0.42%
Q1 2023699.4K$111M+0.29%
Q4 202232.8K$5M+0.01%
Q3 2022193.0K$26M+0.07%
Q2 2022345.0K$53M+0.15%
Q1 20222.20M$356M+0.95%
Q4 20212.11M$285M+0.71%
Q3 2021402.0K$43M+0.11%
Q2 20212.45M$276M+0.73%
Q1 20213.51M$380M+1.04%
Q4 20203.66M$392M+1.05%
Q3 20204.35M$381M+1.09%
Q2 20204.18M$410M+1.19%
Q1 20202.60M$198M+0.76%
Q4 20195.71M$506M+1.17%
Q3 20196.29M$476M+1.17%
Q2 20195.93M$431M+1.07%
Q1 20195.06M$408M+1.03%
Q4 20181.29M$119M+0.32%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Two Sigma Advisers, LP’s full portfolio or all institutional holders of ABBV.